Sodium Bicarbonate in 5% Dextrose Injection recalled over sterility concerns
- Recall date
- August 10, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- SterRx, LLC recalls Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), 1,000 mL bags, Rx only, SterRx, 141…
- Recall number
- D-0767-2021
- FDA classification
- Class I
- Brand / firm
- SterRx, LLC
- Sold / distributed
- Nationwide in the US
Why it was recalled
Non-Sterility: firm's third party lab confirmed microbial contamination.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), 1,000 mL bags, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903 NDC 70324-326-01
Get recall alerts
Free email alert whenever SterRx, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SterRx, LLC